There is a large body of evidence that the anthocyanin Queen Garnet facilitates cognitive and memory function and mood in human subjects. Recent research has investigated the plant compounds and their ...

Neurology experts from UCSF Health presented new clinical research findings and cutting-edge treatment strategies and received distinguished awards recognition at the American Academy of Neurology’s ...

Circulating concentrations of B-type natriuretic peptide (BNP) and the N-terminal fragment (NT) of its prohormone (proBNP) are related to cardiac function and have emerged as clinically useful ...

CD47 is found to play a pivotal role in this immunosuppression by inducing the production of amyloid-β (Aβ), which interacts with CD74 on B cells, leading to B-cell suppression and subsequent adaptive ...

Department of Chemical Engineering, Engineering II Building, University of California, Santa Barbara, Santa Barbara, California 93106-5080, United States ...

A dominant B-cell peptide epitope in patients with CD was identified, located in the highly conserved "hinge region" between the D0 and D1 domains at the amino-terminus of Lachnospiraceae flagellins.

MONDAY, March 24, 2025 (HealthDay News) -- The best evidence yet that cutting-edge Alzheimer’s disease drugs might indeed ward off the degenerative brain disease has emerged from a small-scale ...

An experimental drug that clears amyloid beta from the brain cut the risk of developing Alzheimer’s by 50% among a group of 22 people with genetic mutations that all but guarantee they would ...

Hence, the term “QPCT/L” describes both enzymes at once. Known substrates of the intracellular QPCTL and/or extracellular QPCT are CD47, different chemokines, amyloid-b peptides or hormones like TRH.